Access to single-inhaler triple medicines for chronic obstructive pulmonary disease in China: a national survey on accessibility and utilisation
Background The maintenance medicines for chronic obstructive pulmonary disease (COPD) include inhaled corticosteroids (ICS), long-acting muscarinic antagonists (LAMA) and long-acting β2-agonists (LABA). Budesonide/glycopyrronium/formoterol (BUD/GLY/FOR) and fluticasone furoate/umeclidinium/vilantero...
Saved in:
| Main Authors: | Wei Li, Wei Guo, Hongdou Chen, Wei Lu, Shule Yu, Menglei Wang, Fangfang Zheng, Huanhuan Wu, Qingqing Yang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2025-12-01
|
| Series: | Journal of Pharmaceutical Policy and Practice |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/20523211.2025.2466215 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Access to pediatric oncology medicine in Iran: a cross-sectional survey in Urmia
by: Kiana Baghban, et al.
Published: (2025-08-01) -
Real-World Outcomes of Single-Inhaler Triple Therapy Prescribed by General Practitioners in Managing Chronic Obstructive Pulmonary Disease: A Systematic Literature Review
by: Linet Odonde, et al.
Published: (2025-02-01) -
Impacts of National Reimbursement Drug Price Negotiation on drug accessibility, utilization, and cost in China: a systematic review
by: Zheng Zhu, et al.
Published: (2025-02-01) -
Single-Inhaler Triple Therapy in Primary Care Across Europe: Expert Panel Consensus on the Consequences of Payer-Driven Access Rules and Call to Action
by: Di Marco F, et al.
Published: (2025-05-01) -
Cost-Effectiveness of Single-Inhaler Versus Multiple-Inhaler Triple Therapy in COPD: A German Healthcare Perspective
by: Beeh KM, et al.
Published: (2025-06-01)